Bibliographie
Neurotransmission
J. C. Eccles, « The Mechanism of Synaptic transmission », in Ergebnisse der physiologie – biologischen Chemie und experimentellen Pharmakologie –, , Springer-Verlag, Berlin-Göttingen-Heidelberg, 1961
D. Tritsch, D. Chesnoy-Marchais & A. Feltz, Physiologie du neurone, Doin, Paris, 1998
M. F. Bear, B. W. Connors & M. A. Paradiso, Neuroscience : exploring the brain, Neurosciences : à la découverte du cerveau, traduit et adapté par A. Nieoullon, Masson-Williams & Wilkins France, éd. Pradel, Paris, 1997
J. Epelbaum, Neuropeptides et neuromédiateurs, Laboratoires Sandoz, Rueil-Malmaison, 1992
J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon & A. Goodman Gilman, Goodman & Gilman's The pharmacological basis of therapeutics, McGraw-Hill, 9e éd., 1996
E. R. Kandel, J. H. Schwartz & T. M. Jessell, Principles of neural science, Appleton & Lange, Norwalk, Connecticut, 3e éd., 1991.
Neuropharmacologie
A. I. Basbaum & J. M. Besson, Towands a New Pharmacotherapy of Pain, Wiley, New York, 1991
J. R. Bianchine, « Drugs for Parkinson's diseases
centrally acting muscle relaxants », in A. Goodman, L. S. Gilman et A. Gilman, The Pharmacological Basis of Therapeutics, Mac Millan Publ. Co. Inc., 1981
J. Bogousslavsky, F. Regli & J.-L. Schelling, Pharmacothérapie des affections neurologiques, Lavoisier, Paris, 1988
M. Bourin dir., Médicaments en neurologie et psychiatrie, Masson, Paris, 1990
S. Brailowsky, D. G. Stein & B. Will, Les Dépannages du cerveau, Belin, Paris, 1991
D. B. Calne, « Drug Treatment of spasticity and rigidity », in D. Williams dir., Modern Trends Neurol., vol. VI, Butterworth, Londres, 1980
« Dopaminergic Agonists in the treatment of parkinsonism », in H. L. Klevans dir., Clin. Neuropharmacology, vol. III, A. J. Clark, General Pharmacology, 1937, rééd., Springer, New York, 1970
B. Collier, « Biochemistry and physiology of cholinergic transmission », in J. M. Bookhart et Mountcastle dir., Handbook of Physiol., section I, « The Nervous System », vol. I, part. I, Cellular Biology of Nervous, Amer. Physiol. Soc., Bethesta (Md.), 1977
G. U. Corsini & G. L. Gessa dir., Apomorphine and Other Dopaminomimetics, vol. I : Basic Pharmacology
vol. II : Clinical Pharmacology, Raven Press, 1981
E. Costa, Neurochemical Pharmacology, Raven Press, New York, 1989
H. Dehen & G. Dordain, Neuropharmacologie clinique : le médicament en neurologie, Doin, Paris, 1989
R. A. Davidoff, « Pharmacology of spasticity », in Neurology, vol. XXIX, Minneapolis (Minn.), 1978
H. B. Donahue & K. K. Kimura, « Synthetic Centrally Acting Skeletal Muscle Relaxants », in A. Burger dir., Drugs Affecting the Central Nervous System, Arnold, Londres, 1968
S. N. Dutta, S. N. Pradham & R. P. Maickel, Pharmacology in Medicine, SP Press, Bethesda (Md.), 1986
A. Goldstein, L. Aronow & S. M. Kalmal, Principles of Drug Action : the Basis of Pharmacology, New York, 1969
D. J. Heal & C. A. Marsden, The Pharmacology of Norodrenaline in the Central Nervous System, Oxford Univ. Press, 1990
F. Hoffmeister & G. Stille dir., « Antipsychotics and antidepressants », part. I de « Psychotropic Agents », in Handbook of Experimental Pharmacology, vol. LV, Springer Verlag, Berlin - Heidelberg - New York, 1980
H. L. Klawans, The Pharmacology of Extrapyramidal Movements Disorders, S. Kargan, 1973
H. L. Klawans, C. Goetz & C. M. Tanner, Textbook of Clinical Neuropharmacology and Therapeutics, Raven Press, New York, 1992
A. Picot dir., Neuropharmacologie, école d'été, Lavoisier, 1988
W. S. Root & F. G. Hofmann, Physiological Pharmacology, 5 vol. parus, New York-Londres, depuis 1963
H. Schmitt, Éléments de pharmacologie, Paris, 1980
D. M. Woddbory, J. K. Penry & C. E. Pippenger dir., Antiepileptic Drugs, 2e éd., Raven Press, 1981
M. Ziegler & J.-P. Bleton, La Maladie de Parkinson et son traitement, Frison-Roche, Paris, 1993.
Neurochimie
J. Axelrod & T. Reisine, « Stress Hormones : their interactions and regulations », in Science, vol. CCXXIV, 1984
J. D. Barchas, H. Akil, G. R. Elliott, R. B. Holman & S. J. Watson, « Behavioral Neurochemistry : neuroregulation and behavioral states », ibid., vol. CC, 1978
M. J. Berridge, « Modulation of nervous activity by cyclic nucleotides and calcium », in F. D. Schmidtt and F. G. Worden dir., The Neurosciences Fourth Study Program, The M.I.T. Press, Cambridge, 1979
F. E. Bloom, « Neuropharmacology and the adaptive regulation of receptor sensitivity. An overview », in Neurosciences Research Program Bulletin, vol. XVIII, no 3, 1980
M. D. Browning, R. Huganir & P. Greengard, « Protein Phosphorylation and neuronal function », in Journal of Neurochemistry, vol. XLV, no 1, 1985
J. P. Changeux & F. Revah, « The Acetylcholine Receptor molecule allosteric sites and the ion channel », in Trends in Neurosciences, vol. X, no 6, 1987
M. Comb, S. E. Hyman & H. M. Goodman, « Mechanisms of trans-synaptic regulation of gene expression », in Trends in Neurosciences, vol. X, no 11, 1987
J. T. Coyle & P. Puttfarcken, « Oxidative stress, glutamate and neurodegenerative disorders », in Science, no 262, 1993
L. Descarries, P. Seguela & K. C. Watkins, « Nonjunctional relationship of monoamine axon terminals in the cerebral cortex of adult rat », in K Fuxe & L. F. Agnati, Volume Transmission in the Brain, Raven Press, New York, 1991
G. Ferrari, M. C. Minozzi, G. Toffano et al., « Basic fibroplast growth factor promotes the survival and development of mesencephalic neurons in culture », in Developmental Biology, no 133, 1989
D. D. Ginty, H. Bading & M. E. Greenberg, « Trans-synaptic regulation of gene expression », in Current Opinion in Neurobiology, no 2, 1992
J. A. Girault, « Protein phosphorylation and dephosphorylation in mammabian central nervous system », in Neurochemistry International, no 23, 1993
J. Glowinski, Leçon inaugurale au Collège de France, Paris, 1983
T. Hokfelt, O. Johansson & M. Goldstein, « Chemical Anatomy of the brain », in Science, vol. CCXXIV, 1984
L. E. Hokin, « Receptors and phosphoinositide-generated second messengers », in Annual Review of Biochemistry, vol. LIV, 1985
L. L. Iversen, « Classical signalling in the nervous system », in Progress in Brain Research, no 68, 1986
G. V. W. Johnson & R. S. Jope, « The role of microtabule-associated protein 2 (MAP2) in neuronal growth, plasticity and degeneration », in Neuro-sciences Research, no 33, 1992
J. M. Lundberg & T. Hokfelt, « Multiple co-existence of peptides and classical transmitters in peripheral autonomic and sensory neurons : functional and pharmacological implications », in Progress in Brain Research, no 68, 1986
Y. Masu, E. Wolf, B. Holtmann et al., « Disruption of the CNTF gene results in motor neurone degeneration », in Nature, no 68, 1993
S. Makannishy, « Molecular diversity of glutamate receptors and implications for brain function », in Science, no 258, 1992
A. Nieoullon, « Aspects neurochimiques de la communication interneuronale », in Journal de physiologie, vol. LXXXI, Paris, 1986
M. Peschanski, « La Neuroplasticité », in La Science au présent, Encyclopaedia Universalis, Paris, 1992
H. Reuter « Calcium Channel Modulation by neurotransmitters, enzymes and drugs », in Nature, vol. CCCI, 1983.
Retour en haut
